Current Grants

 

Risk-Benefit Trade-Offs for Whole Genome Sequencing

The objective of this award is to evaluate the benefit-risk trade-offs of genomic sequencing technologies from an individual perspective -how patients make decisions about sequencing and from a societal perspective - how sequencing may impact the health care system.

Funding: NHGRI (R01 HG007063)

Timeframe: 02/15/2013 – 01/31/2017

 

Reimbursement for Whole Exome Sequencing: UCSF as Case Study

The objective of this award is to examine the adoption and reimbursement of Whole Exome Sequencing for pediatric and adult conditions and the implications for clinical care and health policy.

Funding: UCSF Institute for Human Genomics

Timeframe: 01/01/2017 – 12/31/2017

 

Developing Evidence on Reimbursement for the UCSF500 Tumor Profiling Panel Test

Our objective is to collect evidence on reimbursement challenges for Cancer Tumor Profiling (UCSF500) tests and explore how those challenges could be addressed. The goal is to obtain preliminary data and develop a multi-disciplinary team of collaborators that can compete for larger grant funding.

Funding: NUCSF Research Administration Program

Timeframe: 07/01/2017–5/31/2018

 

Genomic sequencing to aid diagnosis in pediatric and prenatal practice

The center grant will focus on generating and analyzing evidence regarding the clinical utility of genome sequencing from the perinatal period into early childhood through examining clinical utility, ethical implications, payer coverage, and data integration in a diverse population.

Funding: NIH/NHGRI (U01HG009599)

Timeframe: 08/01/2017 – 05/31/2021